Merck KGaA, Darmstadt, Germany and Bio-Techne Corp., a Minneapolis-based global provider of life science tools, analytical technologies, and consumables, ...
German drugmaker Merck KGaA said on June 25 it would acquire U.S. life sciences company Bio-Techne for US$11.3 billion, its ...
Merck enters into definitive agreement to acquire Bio-Techne for $11.3 billion: Darmstadt, Germany Saturday, June 27, 2026, 12:00 Hrs [IST] Merck, a leading science and technology ...
Merck KGaA's agreement to buy Bio-Techne for $11.3 billion strengthens its hold in life sciences, especially drug discovery ...
The major stock indexes were mixed on Thursday as slumping mega-cap tech stocks offset a chip stock rally revived by Micron's blowout quarterly results.
Germany’s Merck KGaA will buy Bio-Techne Corp. in a deal worth $11.3 billion, one of the largest acquisitions in Minnesota history. The sale follows investor pressure on Minneapolis-based Bio-Techne, ...
Merck KGaA Darmstadt, Germany worked with its trusted Sullivan & Cromwell team, while Bio-Techne tapped familiar faces at Sidley Austin.
The deal is Merck’s largest since 2015, when it spent $17bn on acquiring Sigma-Aldrich, also a life sciences specialist.
German drugmaker Merck KGaA said on Thursday it will acquire U.S. biotech firm Bio-Techne for $11.3 billion, its largest deal in over a decade.
June 25 (Reuters) - German drugmaker Merck KGaA said on Thursday it would buy U.S. firm Bio-Techne for $11.3 billion, its biggest deal in more than a decade, betting on demand for complex drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results